Tuberculosis remains one of the most lethal infectious diseases caused by a single pathogen. According to the latest global ...

A live-attenuated tuberculosis (TB) vaccine candidate in development at Texas Biomedical Research Institute (Texas Biomed) ...

The BCG Vaccine Laboratory (BCGVL), under the Directorate General of Health Services, Ministry of Health & Family Welfare, is ...

Kenya is among three countries taking part in a major tuberculosis (TB) vaccine trial that will upgrade a vaccine that has been in existence for almost a century.In the country, trials will be ...

A live-attenuated tuberculosis (TB) vaccine candidate in development at Texas Biomedical Research Institute (Texas Biomed) ...

Michigan has the only persisting bovine tuberculosis outbreak in wild deer anywhere in the U.S. — and it occasionally spills ...

In the report, ImmunityBio discusses its significant developments, including receiving a J-code for Anktiva in the U.S., ...

Reports Q4 revenue $7.55M, consensus $9.51M. “The first quarter of 2025 has been an inflection point for the Company with multiple milestones ...

ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced certain operational results following approval of the permanent J-c ...

Not only do malaria and HIV receive far more resources from the Global Fund than tuberculosis, they also get much more global ...

Patna: Despite achieving more than 75% immunisation coverage for most vaccines, Bihar continues to struggle with low coverage ...